Skip to content

Ruxolitinib

Brand name: Jakavi

Ruxolitinib comes in 14 pill versions in our database, in 14 strengths, from 2 manufacturers. Check the imprint to tell them apart.

Ruxolitinib pill images

5 mg 1 pill

5.0 mg 1 pill

10 mg 1 pill

10.0 mg 1 pill

11 mg 1 pill

15 mg 1 pill

15.0 mg 1 pill

20 mg 1 pill

20.0 mg 1 pill

22 mg 1 pill

25.0 mg 1 pill

33 mg 1 pill

44 mg 1 pill

55 mg 1 pill

What is Ruxolitinib used for?

Ruxolitinib is used for polycythemia vera and primary myelofibrosis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Myelofibrosis

JAKAFI/JAKAFI XR is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF in adults.

Polycythemia Vera

JAKAFI/JAKAFI XR is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.

Acute Graft-Versus-Host Disease

JAKAFI/JAKAFI XR is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older.

Chronic Graft-Versus-Host Disease

JAKAFI/JAKAFI XR is indicated for treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

From the FDA-approved label on DailyMed (published Aug 03, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.